Antibody Drug Conjugates (ADC) Market, Indication (Lymphoma, Breast Cancer, Brain Tumor, Lung Cancer

Published Date: | Report Code : HC2068512


Antibody Drug Conjugates (ADC) Market, Indication (Lymphoma, Breast Cancer, Brain Tumor, Lung Cancer, Ovarian Cancer, Others), By Target (Antibody-Protein Toxin Conjugates, Antibody-Chelated Radionuclide Conjugates, Antibody-Small-Molecule Drug Conjugates, Antibody-Enzyme Conjugates), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2068512

Status : Upcoming

The Antibody Drug Conjugates (ADC) Market report points out national and global business prospects and competitive conditions for antibody drug conjugates (ADC). Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for antibody drug conjugates (ADC). The antibody drug conjugates (ADC) market has been segmented indication (lymphoma, breast cancer, brain tumor, lung cancer, ovarian cancer, others), by target (antibody-protein toxin conjugates, antibody-chelated radionuclide conjugates, antibody-small-molecule drug conjugates, antibody-enzyme conjugates). Historical background for the demand of antibody drug conjugates (ADC) has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand antibody drug conjugates (ADC) have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Indication

  • Lymphoma
  • Breast Cancer
  • Brain Tumor
  • Lung Cancer
  • Ovarian Cancer
  • Others

By Target:

  • Antibody-Protein Toxin Conjugates
  • Antibody-Chelated Radionuclide Conjugates
  • Antibody-Small-Molecule Drug Conjugates
  • Antibody-Enzyme Conjugates


By Region:

North America Antibody drug conjugates (ADC) Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Indication
  • North America, by Target

Europe Antibody drug conjugates (ADC) Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Indication
  • Europe, by Target

Asia Pacific Antibody drug conjugates (ADC) Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Indication
  • Asia Pacific, by Target

Middle East & Africa Antibody drug conjugates (ADC) Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Indication
  • Middle East & Africa, by Target

South America Antibody drug conjugates (ADC) Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Indication
  • South America, by Target

Major Companies: Seattle Genetics, Inc., Genentech Inc., Pfizer Inc., Novartis AG, F. Hoffmann-LA Roche Ltd., Bristol -Myers Squibb, Merck & Co., Inc. Immunomedics Inc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for antibody drug conjugates (ADC) market on regional and global basis.
  • To identify major segments in antibody drug conjugates (ADC) market and evaluate their market shares and demand.
  • To provide a competitive scenario for the antibody drug conjugates (ADC) market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of antibody drug conjugates (ADC) market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the antibody drug conjugates (ADC) market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the antibody drug conjugates (ADC)


This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy